101
|
Ogawa Y, Kojima T, Takahashi N, Funahashi K, Ishiguro N. AB0255 The Association between Rheumatoid Factor Positivity and Effects of Treatment with A First Biologic Agent in Rheumatoid Arthritis. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.1337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
102
|
Funahashi K, Kojima T, Takahashi N, Asai S, Takemoto T, Asai N, Watanabe T, Goto T, Shimizu M, Kariya H, Ishiguro N. SAT0069 The Validation about The Measurement of Joint Space Distance by Using Super Resolution Image and Curve Fitting Methods. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.5421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
103
|
Kanayama Y, Kaneko A, Takahashi N, Kato T, Hirano Y, Hattori Y, Asai N, Ishiguro N, Kojima T. AB0334 Clinical Efficacy of Certolizumab Pegol Therapy in Patients with Japanese Active Rheumatoid Arthritis 52 Week Result ∼A Multicenter Registry Study∼. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
104
|
Takahashi N, Kojima T, Funahashi K, Ishiguro N. FRI0206 Sero-Positivity for Rheumatoid Factor Is An Independent Predictor for Achievement of Good Eular Response at 24 Weeks in ACPA Positive Rheumatoid Arthritis Patients Treated with Abatacept: Results from Japanese Multicenter Registry. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
105
|
Umazume T, Yamada T, Morikawa M, Ishikawa S, Kojima T, Cho K, Masauzi N, Minakami H. Occult fetomaternal hemorrhage in women with pathological placenta with respect to permeability. J Obstet Gynaecol Res 2016; 42:632-9. [PMID: 26935605 DOI: 10.1111/jog.12959] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2015] [Accepted: 12/27/2015] [Indexed: 11/27/2022]
Abstract
AIM Women with pre-eclampsia (PE), placenta previa (PP), placental abruption (PA), and placental mesenchymal dysplasia (PMD) have been described as having placental permeability dysfunction. This study was performed to determine whether occult fetomaternal hemorrhage (FMH) is common in women with such complications and in women with non-reassuring fetal status. METHODS Forty-one antenatal and 39 postnatal blood samples were obtained from 46 women, including 11 with placental permeability dysfunction (5, 3, 2, and 1 with PE, PP, PA, and PMD, respectively) and 35 controls without such complications. To estimate the amount of fetal red blood cells, flow cytometry was performed using the fetal cell count system with two antibodies against fetal hemoglobin and carbonic anhydrase and the β-γ system with two monoclonal antibodies against hemoglobin β-chain and hemoglobin γ-chain. A diagnosis of FMH was made when the fraction size of the isolated cell population on scatter plots expressing fetal hemoglobin alone or hemoglobin γ-chain alone accounted for ≥0.02% of the total cell population on scatter plots. RESULTS FMH was identified in five women, including one each with PE, PA, PP, PMD, and no complications. Thus, the prevalence rate of FMH was significantly higher in women with complications than in controls (36% [4/11] vs 2.9% [1/35], respectively, P = 0.009). The FMH occurrence rate did not differ between women with and without non-reassuring fetal status (7.7% [1/13] vs 12% [4/33], respectively, P = 1.000). CONCLUSION The risk of fetal red blood cells trafficking into the maternal circulation may be increased in women complicated with PE, PA, PP, and PMD.
Collapse
|
106
|
Nakamura Y, Ando Y, Takagi Y, Murata M, Kozuka T, Nakata Y, Hasebe R, Takagi A, Matsushita T, Shima M, Kojima T. Distinct X chromosomal rearrangements in four haemophilia B patients with entire F9 deletion. Haemophilia 2015; 22:433-9. [PMID: 26686734 DOI: 10.1111/hae.12849] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2015] [Revised: 06/09/2015] [Accepted: 09/14/2015] [Indexed: 01/31/2023]
Abstract
INTRODUCTION Haemophilia B is an X-linked bleeding disorder caused by a coagulation factor IX gene (F9) abnormality. Numerous F9 defects have been identified to date; however, only a few with an entire F9 deletion have been reported in detail. AIM To elucidate the cause of severe haemophilia B, we investigated the precise X chromosome abnormalities in four Japanese patients who did not show all amplifications in F9-specific PCR. METHODS We analysed the patient's genomic DNA using Multiplex ligation-dependent probe amplification (MLPA). To assess the extent of any deletions, we further performed mapping PCRs, inverse PCRs or long-range PCRs and direct sequencing analyses of the X chromosome. RESULTS We detected entire F9 deletions in four haemophilia B patients and identified the precise deleted regions of the X chromosome including F9. Patient 1 had a 149-kb deletion with breakpoints 90-kb upstream and 30-kb downstream from F9. Patients 2 and 3 showed 273-kb and 1.19-Mb deletions respectively. Patient 4 had two deleted regions: a 1663-bp deletion 1.34-Mb upstream from F9 and a 7.2-Mb deletion including F9. These distinct breakpoints found in four different patients suggest that the mechanism of X chromosome deletion may be different between individuals. Non-allelic homologous recombination (NAHR), microhomology-mediated break-induced replication (MMBIR) or fork stalling and template switching (FoSTeS) may occur in respective X chromosomes of the four haemophilia B patients analysed. CONCLUSIONS We identified diverse X chromosomal rearrangements in four haemophilia B patients, which might be caused by distinct mechanisms of genomic rearrangement.
Collapse
|
107
|
Nomura H, Hatogai K, Suzuki S, Maki Y, Mochizuki N, Tanaka M, Kojima T, Saito S. 1627 Febrile neutropenia in patients with esophageal cancer receiving combination chemotherapy of docetaxel, cisplatin, and 5-fluorouracil. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30715-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
108
|
Hatogai K, Fujii S, Kojima T, Daiko H, Nomura S, Doi T, Ochiai A, Yoshino T. 2405 Comprehensive biomarker analyses in esophageal squamous cell carcinoma. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31321-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
109
|
Takatsuji H, Kobayashi T, Kojima T, Hasebe D, Izumi N, Saito I, Saito C. Effects of orthognathic surgery on psychological status of patients with jaw deformities. Int J Oral Maxillofac Surg 2015; 44:1125-30. [DOI: 10.1016/j.ijom.2015.02.003] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2014] [Revised: 12/11/2014] [Accepted: 02/03/2015] [Indexed: 10/23/2022]
|
110
|
Sakai N, Yabuuchi H, Kondo M, Matsuo Y, Kamitani T, Nagao M, Jinnouchi M, Yonezawa M, Kojima T, Yano Y, Honda H. Low-dose CT screening using hybrid iterative reconstruction: confidence ratings of diagnoses of simulated lesions other than lung cancer. Br J Radiol 2015; 88:20150159. [PMID: 26153902 DOI: 10.1259/bjr.20150159] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
OBJECTIVE To evaluate the confidence ratings of diagnoses of simulated lesions other than lung cancer on low-dose screening CT with hybrid iterative reconstruction (IR). METHODS Simulated lesions (emphysema, mediastinal masses and interstitial pneumonia) in a chest phantom were scanned by a 320-row area detector CT. The scans were performed by 64-row and 160-row helical scans at various dose levels and were reconstructed by filtered back projection (FBP) and IR. Emphysema, honeycombing and reticular opacity were visually scored on a four-point scale by six thoracic radiologists. The ground-glass opacity as a percentage of total lung volume (%GGO), CT value and contrast-to-noise ratio (CNR) of mediastinal masses were calculated. These scores and values were compared between FBP and IR. Wilcoxon's signed-rank test was used (p < 0.05). Interobserver agreements were evaluated by κ statistics. RESULTS There were no significant differences in visual assessment. Interobserver agreement was almost perfect. CT values were almost equivalent between FBP and IR, whereas CNR with IR was significantly higher than that with FBP. %GGO significantly increased at low-dose levels with FBP; however, IR suppressed the elevation. CONCLUSION The confidence ratings of diagnoses of simulated lesions other than lung cancer on low-dose CT screening were not degraded with hybrid IR compared with FBP. ADVANCES IN KNOWLEDGE Hybrid IR did not degrade the confidence ratings of diagnoses on visual assessment and differential diagnoses based on CT value of mediastinal masses, and it showed the advantage of higher GGO conspicuity at low-dose level. Radiologists can analyse images of hybrid IR alone on low-dose CT screening for lung cancer.
Collapse
|
111
|
Hirano Y, Hayashi M, Hirabara S, Takahashi N, Kanayama Y, Kaneko A, Kojima T, Ishiguro N. SAT0178 Predictors of Effectiveness in Golimumab Treatment and Efficacy of Dose-Escalation of Golimumab in Patients with Rheumatoid Arthritis – A Multicenter Registry Study TBCR. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1247] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
112
|
Kojima T, Takahashi N, Kaneko A, Kida D, Hirano Y, Fujibayashi T, Yabe Y, Takagi H, Oguchi T, Miyake H, Kato T, Watanabe T, Hayashi M, Shioura T, Kanayama Y, Funahashi K, Asai S, Yoshioka Y, Terabe K, Takemoto T, Asai N, Ishiguro N. THU0115 Importance of Both Disease Activity at 12 Weeks and Clinical Response up to 12 Weeks to Predict Achievement of Low Disease Activity at 52 Weeks During Abatacept Treatment in Biologics-Switching Patients with Rheumatoid Arthritis: A Multicenter Observational Cohort Study in Japan. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1318] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
113
|
Takahashi N, Kojima T, Funahashi K, Ishiguro N. FRI0178 Positivity for Rheumatoid Factor is Associated with a Better Short-Term Response and Long-Term Drug Retention of Abatacept: Results from Consecutive 508 Patients with Rheumatoid Arthritis in a Japanese Multicenter Registry. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
114
|
Hirano Y, Hirabara S, Isono M, Oishi Y, Kojima T, Ishiguro N. SAT0138 Analysis of Treatment Retention Rate of Biologics Therapy in Patients with Rheumatoid Arthritis – A Single Center Cohort Study. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
115
|
Hattori Y, Kaneko A, Kida D, Takahashi N, Kanda H, Kojima T, Ishiguro N. SAT0177 The Combination of Serum Matrix Metalloproteinase-3 and C-Reactive Protein at 4 Weeks Predict High Continuation Rate in RA Patients with Adalimumab Therapy. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.4327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
116
|
Hattori Y, Kaneko A, Kida D, Kanayama Y, Hirano Y, Kanda H, Kojima T, Ishiguro N. FRI0142 Efficacy of the Initial Treatment with Certolizumab Pegol for Rheumatoid Arthritis: A Multicenter Study. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.6009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
117
|
Hirano Y, Hirabara S, Isono M, Oishi Y, Kojima T, Ishiguro N. FRI0287 Daily Teriparatide Treatment for Two Years on Osteoporosis in Patients with Rheumatoid Arthritis – Impact of Concomitant Drugs (Prednisolone and Biologics) on Effects of Teriparatide. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
118
|
Hirano Y, Hirabara S, Isono M, Oishi Y, Kojima T, Ishiguro N. AB0488 Influences of 2-Year Tocilizumab Therapy on Disease Activity, Quality of Life, Prevention of Joint Damage and Reduction of Concomitant Drugs (Prednisolone and Methotrexate) in Patients with Rheumatoid Arthritis. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
119
|
Hattori Y, Kaneko A, Kida D, Hirano Y, Fujibayashi T, Takahashi N, Terabe K, Kanda H, Kojima T, Ishiguro N. FRI0141 Retention Rate and Discontinuation Due to Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis Receiving Adalimumab Therapy: A Multicenter Study. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
120
|
Hanabayashi M, Takahashi N, Miyake H, Yokota Y, Kojima T, Ishiguro N. FRI0174 The Clinical Outcome of Abatacept Therapy in Single Biologic Failure and Multiple Biologic Failure with Rheumatoid Arthritis Patients -Results from Japanese Multi Center Registry System-. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.5493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
121
|
Hirabara S, Kojima T, Takahashi N, Kaneko A, Kida D, Hirano Y, Ishiguro N. FRI0098 The Safety and Treatment Efficacy of Abatacept in Rheumatoid Arthritis Patients with Interstitial Lung Disease: From the Tsurumai Biologics Communication Registry (TBCR) Multicenter Study. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
122
|
Hirabara S, Kojima T, Takahashi N, Yabe Y, Kaneko A, Kida D, Hirano Y, Ishiguro N. AB0480 Clinical Efficacy of TNF Inhibitors and Abatacept in Japanese Rheumatoid Arthritis Patients Switching from Tocilizumab. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
123
|
Watanabe T, Kojima T, Takahashi N, Funahashi K, Asai S, Takemoto T, Asai N, Ishiguro N. AB1181 The Impact of Physical Function on Patient Global Assessment in Rheumatoid Arthritis. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
124
|
Hirano Y, Kanayama Y, Kanda H, Saito K, Hirabara S, Takahashi N, Ito T, Kaneko A, Kojima T, Ishiguro N. AB0515 Influences of Disease Activity at the Initiation of Iguratimod, a Small Molecule Antirheumatic Drug, on Efficacy of Iguratimod in Patients with Rheumatoid Arthritis – 52 Weeks Results from a Multicenter Registry Study TBCR. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
125
|
Kojima T, Ishikawa H, Nishida K, Hashimoto J, Miyahara H, Tanaka S, Haga N, Niki Y, Kojima M, Ishiguro N. THU0602 Relationship Between Index of Activity Speed (Time Up and Go Test) and Patient-Reported Outcome in Patients with Long-Standing Rheumatoid Arthritis: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|